Andhra Bank plans stake sale in IndiaFirst Life
Andhra Bank plans stake sale in IndiaFirst Life

Andhra Bank plans stake sale in IndiaFirst Life

Dnyanada Kulkarni Article rating: 4.5

Andhra Bank intends to sell its 30 per cent stake in IndiaFirst Life Insurance Company either in part or in full. By doing so, it aspires to raise Rs. 900 crore. One of the candidates who could potentially purchase the stake is the existing investor, Warburg Pincus.

Should you dispose of your real estate investment and buy mutual funds?
Should you dispose of your real estate investment and buy mutual funds?

Should you dispose of your real estate investment and buy mutual funds?

Henil Shah Article rating: 4.0

Many financial advisers have been asking people to invest in mutual funds rather than real estate due to good returns in the long-term. So, should you dispose of your real estate investment and invest in mutual funds? Let’s find out.

Aarti Industries signs supply contract worth Rs. 900 crore
Aarti Industries signs supply contract worth Rs. 900 crore

Aarti Industries signs supply contract worth Rs. 900 crore

Apurva Joshi Article rating: 5.0

Aarti Industries has entered a supply contract with a leading global chemical conglomerate. The Rs. 900 crore contract includes the supply of a high-value speciality chemical intermediate for a period of 10 years.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

Shital Jibhe Article rating: 5.0

The markets on February 20, 2019 opened gap up. BSE Sensex is trading at 35,520.11, up by 167.50 points and the Nifty is trading at 10,656.70, up by 52.35 points. 

US court allows Dr. Reddys to sell generic Suboxone film
US court allows Dr. Reddys to sell generic Suboxone film

US court allows Dr. Reddys to sell generic Suboxone film

Advait Dharmadhikari Article rating: 5.0

Pharma major Dr. Reddy’s Labs won a legal battle against Indivior, a British drugmaker, in the US as the US Chief Justice allowed the company to resume selling the generic version of Suboxone Film which is Indiviors' opioid addiction treatment drug.

Markets shine with metals
Markets shine with metals

Markets shine with metals

Gayathri Udyawar Article rating: 5.0

Benchmark indices were moving upward in the morning session on Wednesday. This was a broad based upmove with good participation from mid-cap and small-cap stocks. The market seemed to be reacting to global cues wherein the US markets gained on the back of good earnings and scheduled US Fed's policy meet.

Indian Hotels forays into homestay segment
Indian Hotels forays into homestay segment

Indian Hotels forays into homestay segment

Advait Dharmadhikari Article rating: 4.6

The Tata Group company has claimed that this is the first branded product in the homestay market in the country. The brand will operate under two sub-brands namely Ama Plantation Trails and Ama Fine Homestays.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.40 crore contracts with a turnover of Rs. 8,68,444.29 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.40 crore contracts with a turnover of Rs. 8,68,444.29 crore.

RSS
First26792680268126822684268626872688Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR